Legal Representation
Attorney
Nancy Rubner Frandsen
USPTO Deadlines
Next Deadline
1216 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-11-15)
Due Date
November 15, 2028
Grace Period Ends
May 15, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 15, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 15, 2022 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 30, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 30, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 10, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jul 25, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jul 22, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 21, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 21, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 11, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 11, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 11, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 29, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 27, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 2, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Diagnostic services in the field of molecular genetics diagnostics through DNA/RNA extractions/purifications, DNA sequencing through next generation sequencing, gene expression and genotyping through open array technology
First Use Anywhere:
Jul 1, 2019
First Use in Commerce:
Jul 1, 2019
Class 044
Medical testing for diagnostic or treatment purposes in the field of infectious diseases testing, genotyping testing (pharmacogenomics), next generation sequencing, namely, common hereditary cancer genomics, cardiomyopathy, carrier testing screening, Alzheimer-Parkinson's-Dimentia, non-invasive prenatal screening
First Use Anywhere:
Jul 1, 2019
First Use in Commerce:
Jul 1, 2019
Classification
International Classes
042
044
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"LABORATORY"